PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...

Results from 40 infants with persistent pulmonary hypertension of the newborn (PPHN), an often fatal complication, were compared with those of 61 randomly selected, healthy, full-term infants.

also known as elevation-induced pulmonary hypertension. High altitude can cause or worsen hypertension in some people by affecting the body’s gas exchange process and reducing oxygen saturation.